Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 2/20 | 0.65 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | DGKA | P23743 | 2/20 | 0.45 |
| ▸ | USP2 | O75604 | 1/20 | 0.42 |
| ▸ | MGLL | Q99685 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | CNR1 | P21554 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL560301 | 0.96 | ALOX15 (0.63) | ALOX15EPHX2ALDH1A1DGKAUSP2 | |
| SCHEMBL2171493 | 0.94 | ALOX15 (0.61) | ALOX15EPHX2ALDH1A1DGKAMAPT | |
| SCHEMBL19242397 | 0.94 | ALOX15 (0.61) | ALOX15EPHX2ALDH1A1DGKAMAPT | |
| SCHEMBL8664640 | 0.94 | ALOX15 (0.61) | ALOX15EPHX2ALDH1A1DGKAMAPT | |
| SCHEMBL19900625 | 0.94 | ALOX15 (0.61) | ALOX15EPHX2ALDH1A1DGKAMAPT | |
| SCHEMBL8840230 | 0.92 | ALOX15 (0.71) | ALOX15EPHX2ALDH1A1DGKAUSP2 | |
| SCHEMBL28414392 | 0.92 | ALOX15 (0.71) | ALOX15EPHX2ALDH1A1DGKAUSP2 | |
| SCHEMBL310496 | 0.91 | ALOX15 (0.69) | ALOX15EPHX2ALDH1A1DGKAUSP2 | |
| SCHEMBL10583022 | 0.91 | ALOX15 (0.69) | ALOX15EPHX2ALDH1A1DGKAUSP2 | |
| SCHEMBL8840007 | 0.91 | ALOX15 (0.69) | ALOX15EPHX2ALDH1A1DGKAUSP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 257 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2018145219-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING ADDICTIONS BY MEANS OF AVERSIVE COUNTERCONDITIONING | SERANI MOSTAZAL JORGE (CL) | 2018-08-16 | — | — | WO | claimed |
| JP-4739231-B2 | — | — | 2011-08-03 | — | — | JP | claimed |
| EP-1716159-B1 | BICYCLIC SILOXANE COMPOSITIONS FOR THE RELEASE OF ACTIVE INGREDIENTS | MOMENTIVE PERFORMANCE MAT INC (US) | 2011-07-13 | — | — | EP | claimed |
| US-7579495-B2 | Active-releasing cyclic siloxanes | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2009-08-25 | — | — | US | claimed |
| US-7576170-B2 | Cyclic siloxane compositions for the release of active ingredients | MOMENTIVE PERFORMANCE MATERIALS (US) | 2009-08-18 | — | — | US | claimed |
| US-20080015262-A1 | Pest Treatment Composition | BTG INTERNATIONAL INC. (US) | 2008-01-17 | — | — | US | claimed |
| EP-1697386-B1 | ACTIVE INGREDIENT-RELEASING CYCLIC SILOXANES | GEN ELECTRIC (US) | 2007-10-10 | — | — | EP | claimed |
| CN-1893910-A | Cyclic siloxane compositions for active ingredient release | GEN ELECTRIC (US) | 2007-01-10 | — | — | CN | claimed |
| EP-1716159-A2 | CYCLIC SILOXANE COMPOSITIONS FOR THE RELEASE OF ACTIVE INGREDIENTS | General Electronic Company (US) | 2006-11-02 | — | — | EP | claimed |
| EP-1697386-A1 | ACTIVE INGREDIENT-RELEASING CYCLIC SILOXANES | General Electric Company A Corporation of the State of New York (US) | 2006-09-06 | — | — | EP | claimed |
| WO-2005066187-A1 | ACTIVE INGREDIENT-RELEASING CYCLIC SILOXANES | GENERAL ELECTRIC COMPANY (US) | 2005-07-21 | — | — | WO | claimed |
| WO-2005066186-A2 | CYCLIC SILOXANE COMPOSITIONS FOR THE RELEASE OF ACTIVE INGREDIENTS | GENERAL ELECTRIC COMPANY (US) | 2005-07-21 | — | — | WO | claimed |
| US-20050136022-A1 | Cyclic siloxane compositions for the release of active ingredients | MOMENTIVE PERFORMANCE MATERIALS INC. | 2005-06-23 | — | — | US | claimed |
| US-20050136021-A1 | Active-releasing cyclic siloxanes | MOMENTIVE PERFORMANCE MATERIALS INC. | 2005-06-23 | — | — | US | claimed |
| US-20030228342-A1 | Pest treatment composition | EFFCON LABORATORIES, INC. | 2003-12-11 | — | — | US | claimed |
| WO-2001089503-A1 | PEST TREATMENT COMPOSITION | EFFCON LABORATORIES, INC. (US) | 2001-11-29 | — | — | WO | claimed |
| WO-2001012173-A1 | LOW CONCENTRATION PEST TREATMENT COMPOSITION AND METHOD | EFFCON LABORATORIES, INC. (US) | 2001-02-22 | — | — | WO | claimed |
| US-20260096991-A1 | BIODEGRADABLE MICROCAPSULES AND METHOD FOR THEIR PREPARATION | XAMPLA LTD (GB) | 2026-04-09 | — | — | US | disclosed |
| US-5800897-A | Air freshener composition containing a fiber pad | EASTMAN CHEMICAL COMPANY (US) | 1998-09-01 | — | — | US | disclosed |
| WO-1997026926-A1 | AIR FRESHENER COMPOSITION CONTAINING A FIBER PAD | EASTMAN CHEMICAL COMPANY (US) | 1997-07-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260096991-A1 | BIODEGRADABLE MICROCAPSULES AND METHOD FOR THEIR PREPARATION | PCTP, CLK4, MTCL3 | ALOX15 4169/4885EPHX2 3512/4885ALDH1A1 4813/4885 |
| US-20050136022-A1 | Cyclic siloxane compositions for the release of active ingredients | F9, RPL39, ECPAS | ALOX15 868/4885EPHX2 333/4885ALDH1A1 44/4885 |
| US-20050136021-A1 | Active-releasing cyclic siloxanes | F9, RPL39, ALDH16A1 | ALOX15 797/4885EPHX2 581/4885ALDH1A1 57/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.